In August 2012 stools gained the front cover The Economist. The issue hosted a long article on the newly discovered relationships between stool bacteria (the gut microbiota – GMB) and the human host. The GMB has recently been reconceptualised as yet another body organ, with an intense cross-talk with a number of other organs, including the brain. The mediators of the gut-brain cross-talk are circulating mediators, neural circuits and the immune-inflammatory system. Evidence is mounting that the GMB can affect normal human behavior and some psychiatric diseases such as autism. A pivotal role of the native GMB has been demonstrated in mouse models of multiple sclerosis.
The focus of this conference is to inform specialists and researchers of the relevance and opportunities brought about by recent evidence on the role of the GMB in human brain diseases and to develop a network of Swiss scientists to study the effect of the GMB in Alzheimer’s disease.
Save the date !
Nov 3rd, 2015, 13h30 at Campus Biotech
(complete program will follow soon)